These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8266611)

  • 41. Presence of CSE1L protein in urine of patients with urinary bladder urothelial carcinomas.
    Tai CJ; Liao CF; Su TC; Shen KH; Chang CC; Lin SH; Yeh CM; Shen SC; Lee WR; Chiou JF; Lin CH; Chen YC; Shih HY; Yeh KT; Jiang MC
    Int J Biol Markers; 2012 Oct; 27(3):e280-4. PubMed ID: 22653741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential PTEN protein expression profiles in superficial versus invasive bladder cancers.
    Koksal IT; Yasar D; Dirice E; Usta MF; Karauzum S; Luleci G; Baykara M; Sanlioglu S
    Urol Int; 2005; 75(2):102-6. PubMed ID: 16123561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary cytokeratin 20 as a marker for transitional cell carcinoma.
    Rotem D; Cassel A; Lindenfeld N; Mecz Y; Sova Y; Resnick M; Stein A
    Eur Urol; 2000 May; 37(5):601-4. PubMed ID: 10765100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary level of CA19-9 as a tumor marker in urothelial carcinoma of the bladder.
    Pal K; Roy S; Mondal SA; Chatterjee U; Tiwari P; Bera M
    Urol J; 2011; 8(3):203-8. PubMed ID: 21910099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BTA TRAK urine test increases the efficacy of cytology in the diagnosis of low-grade transitional cell carcinoma of the bladder.
    Gibanel R; Ribal MJ; Filella X; Ballesta AM; Molina R; Alcaraz A; Alcover JB
    Anticancer Res; 2002; 22(2B):1157-60. PubMed ID: 12168917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunocytochemistry of collagenase expression in transitional cell carcinoma of the bladder.
    Hattori M; Ohno E; Kuramoto H
    Acta Cytol; 2000; 44(5):771-7. PubMed ID: 11015978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.
    Curigliano G; Ferretti G; Flamini G; Goldhirsch A; de Braud F; Calabro MG; Mandaly M; Nole F; De Pas T; D'Addessi A; Cittadini A
    Anticancer Res; 2001; 21(4B):3015-20. PubMed ID: 11712804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using tree analysis pattern and SELDI-TOF-MS to discriminate transitional cell carcinoma of the bladder cancer from noncancer patients.
    Liu W; Guan M; Wu D; Zhang Y; Wu Z; Xu M; Lu Y
    Eur Urol; 2005 Apr; 47(4):456-62. PubMed ID: 15774241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significance of tissue laminin P(1) elastase and fibronectin levels in transitional cell carcinoma of the bladder.
    Kirkali G; Tüzel E; Güler C; Gezer S; Kirkali Z
    Eur Urol; 2001 Mar; 39(3):292-9. PubMed ID: 11275722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary markers in the everyday diagnosis of bladder cancer.
    Dal Moro F; Valotto C; Guttilla A; Zattoni F
    Urologia; 2013; 80(4):265-75. PubMed ID: 24419920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combinations of urine-based tumour markers in bladder cancer surveillance.
    Horstmann M; Patschan O; Hennenlotter J; Senger E; Feil G; Stenzl A
    Scand J Urol Nephrol; 2009; 43(6):461-6. PubMed ID: 19903092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
    Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
    Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.
    Hotakainen K; Haglund C; Paju A; Nordling S; Alfthan H; Rintala E; Stenman UH
    Eur Urol; 2002 Jun; 41(6):677-85. PubMed ID: 12074787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma.
    Li LY; Yang M; Zhang HB; Su XK; Xu WF; Chen Y; Shen ZJ; Gao X
    BJU Int; 2008 Aug; 102(5):566-71. PubMed ID: 18410436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Value of immunohistochemical laminin staining in transitional cell carcinoma of human bladder.
    Abou Farha KM; Janknegt RA; Kester AD; Arends JW
    Urol Int; 1993; 50(3):133-40. PubMed ID: 7682019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.